1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies
(
- Contribution to journal › Article
- 2022
-
Mark
Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies
(
- Contribution to journal › Article
- 2021
-
Mark
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
(
- Contribution to journal › Article
- 2020
-
Mark
Autoimmune congenital heart block and primary Sjögren's syndrome : characterisation and outcomes of 49 cases
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
(
- Contribution to journal › Article
- 2019
-
Mark
Efficacy and safety of topical and systemic medications : A systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
(
- Contribution to journal › Article
-
Mark
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients : A cross-sectional study from the Big Data Sjögren Project Consortium
(
- Contribution to journal › Article
- 2016
-
Mark
Sjögren syndrome
(
- Contribution to journal › Article
-
Mark
Development of the ClinESSDAI : A clinical score without biological domain. A tool for biological studies
(
- Contribution to journal › Article